Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.

Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.

A randomised, double blind, placebo controlled, crossover study of digoxin withdrawal and reintroduction was carried out over two periods of eight weeks each after long term treatment. Forty four patients with stable heart failure in sinus rhythm and plasma digoxin concentrations over 0.8 ng/ml were...

Bibliografiset tiedot
Päätekijät:	Pugh, SE, White, N, Aronson, J, Grahame-Smith, D, Bloomfield, J
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	BMJ Publishing Group 1989

Samankaltaisia teoksia

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
Tekijä: Pugh, S, et al.
Julkaistu: (1982)

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
Tekijä: Aronson, J, et al.
Julkaistu: (1978)

In vivo cation transport during short-term and long-term digoxin therapy.
Tekijä: Boon, N, et al.
Julkaistu: (1986)

Digoxin in advanced heart failure patients: A question of rhythm
Tekijä: Elisabete Jorge, et al.
Julkaistu: (2013-04-01)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and haemodynamic performance of an isolated, perfused, working guinea-pig heart.
Tekijä: Zannad, F, et al.
Julkaistu: (1982)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
Tekijä: Ford, A, et al.
Julkaistu: (1979)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
Tekijä: Aronson, J, et al.
Julkaistu: (1977)

Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.
Tekijä: Ford, A, et al.
Julkaistu: (1979)

Digoxin revisited.
Tekijä: Aronson, J
Julkaistu: (1998)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
Tekijä: Ford, A, et al.
Julkaistu: (1979)

Interaction of digoxin with quinine.
Tekijä: Aronson, J, et al.
Julkaistu: (1981)

A method for the study of cation transport in vivo: effects of digoxin administration and of chronic renal failure on the disposition of an oral load of rubidium chloride.
Tekijä: Boon, N, et al.
Julkaistu: (1984)

Clinical pharmacokinetics of digoxin 1980.
Tekijä: Aronson, J
Julkaistu: (1980)

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE
Tekijä: Aronson, J, et al.
Julkaistu: (1983)

Indications for the measurement of plasma digoxin concentrations.
Tekijä: Aronson, J
Julkaistu: (1983)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
Tekijä: Aronson, J, et al.
Julkaistu: (1977)

ABC of monitoring drug therapy. Digoxin.
Tekijä: Aronson, J, et al.
Julkaistu: (1992)

Digoxin and Heart Failure: Are We Clear Yet?
Tekijä: Amit Gupta, et al.
Julkaistu: (2017-04-01)

EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY
Tekijä: Boon, N, et al.
Julkaistu: (1984)

A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole.
Tekijä: Wood, A, et al.
Julkaistu: (1989)

Monitoring digoxin therapy: III. How useful are the nomograms?
Tekijä: Aronson, J
Julkaistu: (1978)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
Tekijä: Aronson, J, et al.
Julkaistu: (1982)

The effect of digoxin on renal function in patients with heart failure
Tekijä: Parin Shah, et al.
Julkaistu: (2021-10-01)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
Tekijä: Aronson, J, et al.
Julkaistu: (1980)

Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry.
Tekijä: Jo-Jo Hai, et al.
Julkaistu: (2016-01-01)

Risk of stroke in patients with heart failure and sinus rhythm: data from the Swedish Heart Failure Registry
Tekijä: Clara Hjalmarsson, et al.
Julkaistu: (2021-02-01)

Clinical pharmacology. Adverse drug interactions.
Tekijä: Aronson, J, et al.
Julkaistu: (1981)

THE EFFECTS OF DIGOXIN AND DOPAMINE ON THE OXYGEN-CONSUMPTION, LACTATE PRODUCTION AND PERFORMANCE OF AN ISOLATED, PERFUSED WORKING GUINEA-PIG HEART
Tekijä: Zannad, F, et al.
Julkaistu: (1982)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and performance of an isolated, perfused working guinea-pig heart
Tekijä: Zannad, F, et al.
Julkaistu: (1982)

Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?
Tekijä: Jain Shreepal, et al.
Julkaistu: (2009-01-01)

Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction
Tekijä: Jingmin Zhou, et al.
Julkaistu: (2020-02-01)

Left Atrial Strain to Predict Stroke in Patients With Acute Heart Failure and Sinus Rhythm
Tekijä: Jae‐Hyeong Park, et al.
Julkaistu: (2021-07-01)

Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm
Tekijä: Francesc Formiga, et al.
Julkaistu: (2022-10-01)

Echocardiographic predictors of severe heart failure symptoms in hypertrophic cardiomyopathy patients with sinus rhythm
Tekijä: Degertekin Muzaffer, et al.
Julkaistu: (2008-02-01)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
Tekijä: Sophia Sheikh, et al.
Julkaistu: (2024-06-01)

Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients
Tekijä: Ioanna Koniari, et al.
Julkaistu: (2022-05-01)

Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension
Tekijä: Kevin Y. Chang, et al.
Julkaistu: (2023-03-01)

Haemodynamic determinants of quality of life in chronic heart failure
Tekijä: Serlie Fatrin, et al.
Julkaistu: (2022-09-01)

Haemodynamic effects of sacubitril/valsartan in advanced heart failure
Tekijä: Piero Gentile, et al.
Julkaistu: (2022-04-01)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
Tekijä: M Yurdakök, et al.
Julkaistu: (1989-10-01)